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ABSTRACT
Atrial natriuretic peptide (nppa/anf ) and brain natriuretic peptide
(nppb/bnp) form a gene cluster with expression in the chambers of the
developing heart. Despite restricted expression, a function in cardiac
development has not been demonstrated by mutant analysis. This is
attributed to functional redundancy; however, their genomic location
in cis has impeded formal analysis. Using genome editing, we have
generated mutants for nppa and nppb, and found that single mutants
were indistinguishable from wild type, whereas nppa/nppb double
mutants displayed heart morphogenesis defects and pericardial
oedema. Analysis of atrioventricular canal (AVC) markers show
expansion of bmp4, tbx2b, has2 and versican expression into the
atrium of double mutants. This expanded expression correlates with
increased extracellular matrix in the atrium. Using a biosensor for
hyaluronic acid to measure the cardiac jelly (cardiac extracellular
matrix), we confirmed cardiac jelly expansion in nppa/nppb double
mutants. Finally, bmp4 knockdown rescued the expansion of has2
expression and cardiac jelly in double mutants. This definitively
shows that nppa and nppb function redundantly during cardiac
development to restrict gene expression to the AVC, preventing
excessive cardiac jelly synthesis in the atrial chamber.
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INTRODUCTION
At early stages of development [24-30 h post fertilisation (hpf) in
the zebrafish], the heart is a double-layered linear tube, with an
inner layer of endothelium (called the endocardium) and an
outer muscular layer called the myocardium. During cardiac
morphogenesis in both zebrafish and mice, the prospective atrial
and ventricular chambers of the heart ‘balloon’ out of the heart tube,
becoming morphologically and genetically distinct from the
atrioventricular canal (AVC). The AVC is a specialised region of
the developing heart that partitions the two chambers. It is
characterised by Bmp2/4 (Keyes et al., 2003; Ma et al., 2005;
Walsh and Stainier, 2001) and Tbx2 (Chi et al., 2008; Christoffels
et al., 2004; Harrelson et al., 2004) gene expression in the
myocardium and Has2 gene expression in the endocardium (Tien
and Spicer, 2005). Has2 encodes a synthetic enzyme of the
extracellular matrix component, hyaluronic acid (HA), and,
congruent with its expression, localised swellings of extracellular
matrix (ECM; known as ‘cardiac jelly’) are observed at the AVC.
These swellings are the endocardial cushions: primitive structures
that will later remodel to form cardiac valve leaflets.
The hierarchical relation between Bmp2/4 and Tbx2 has been
extensively described, both in fish and mammals. Bmp2/4 and Tbx2
depletion share the phenotype of impaired AV boundary
establishment (Chi et al., 2008; Harrelson et al., 2004; Ma et al.,
2005) and reduced Bmp signalling results in undetectable
expression of Tbx2 in the AVC myocardium, placing Bmp
signalling upstream of Tbx2 (Ma et al., 2005; Shirai et al., 2009;
Verhoeven et al., 2011). The zebrafish jekyll mutant, which
harbours a mutation in the UDP-glucose 6-dehydrogenase gene
(another enzyme of the HA biosynthetic pathway), and Has2-null
mice show a key function for the cardiac jelly in determining both
correct patterning and early localised growth of the endocardial
cushions (Camenisch et al., 2000; Walsh and Stainier, 2001).
Although Bmp2/4 and Tbx2 are restricted to the AVC, Nppa (also
known as ANF, atrial natriuretic factor) and Nppb (also known as
BNP, brain natriuretic peptide) represent their chamber myocardium
counterpart: Nppa and Nppb expression are enriched in the
ballooning surfaces of the cardiac tube, and Nppa is actively
excluded from the AVC by the repressive function of Tbx2 (Becker
et al., 2014; Christoffels et al., 2004; Habets et al., 2002). Despite
their compelling expression patterns, little has been reported about
the function of Nppa and Nppb during heart development. Nppa- or
Nppb-null mice lack any obvious developmental phenotype (John
et al., 1995; Tamura et al., 2000). Nppa and Nppb lie in a conserved
gene cluster (Inoue et al., 2003; Tamura et al., 1996) with common
regulatory regions that become activated during development
(Sergeeva et al., 2016). This co-regulation, their homology and
the absence of developmental phenotypes observed in response to
single gene loss of function has led to the hypothesis that these two
genes are functionally redundant.
Here, we describe the generation of single and double nppa and
nppb zebrafish mutants, which is now possible with genome-
editing methods. Consistent with previous reports, single mutants
exhibit no overt developmental phenotype. In contrast, double
mutants exhibit pericardial oedema, expanded AVC markers and
thickening of the cardiac jelly in the atrium of the early embryonic
heart. These data support the notion that nppa and nppb function
redundantly, and demonstrate that nppa/nppb double mutants play
a previously unappreciated role in cardiac development by restricting
AVC gene expression and repressing ECM accumulation in the atrial
chamber.Received 19 October 2017; Accepted 2 May 2018
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RESULTS AND DISCUSSION
nppa and nppb act redundantly during early cardiac
morphogenesis
In zebrafish, the nppa and nppb loci reside in a gene cluster on
chromosome 8, separated by approximately 2.5 kb (Fig. 1A). This
proximity precludes a classical strategy of generating double
homozygous mutants by homologous recombination. To
overcome this, we undertook sequential mutagenesis of the two
loci, first generating an nppamutant line using TALEN technology,
and then targeting the nppb locus in the nppa mutant background
using the CRISPR/Cas9 system. Simultaneously, nppb single
mutants were created. For nppa, exon 1 was targeted, producing a
4 bp deletion at 55 bp of the coding region (nppauq19ks). This results
in normal protein sequence until amino acid 18, followed by
frameshifted sequence to amino acid 23 and then translational
termination (Fig. 1A,B), preventing generation of the 139 amino
acid wild-type protein. For nppb, exon 2 was targeted and two
alleles were generated. The mutant locus nppbuq20ks, which is linked
in cis to the nppauq19ks allele, carries a 39 bp insertion containing
a stop codon, resulting in a shorter protein of 80 amino acids
(Fig. 1A,B; full-length wild-type protein contains 129 amino acids).
The single nppbuq21ks mutant allele harbours a 10 bp frameshift
insertion at amino acid 80, encoding 15 out-of-frame amino acids
until termination at 95 amino acids in length (Fig. 1A,B). In all three
instances, the mutated forms of Nppa and Nppb lack the C-terminal
region of the protein, which contains the mature peptides produced
following processing (Fig. 1B) (Bloch et al., 1985). Given that
targeting the propeptide region of Nppa has previously been shown
to result in undetectable amounts of Nppa protein (John et al., 1995),
we surmise that the nppauq19ks, nppbuq20ks and nppbuq21ks alleles are
functional nulls.
The incross of nppa+/uq19ks and nppb+/uq21ks single carriers
generated embryos that, at the developmental stages analysed [48,
72 and 96 h post fertilisation (hpf )], appeared wild type, thus in line
with the absence of phenotype in Nppa−/− and Nppb−/− mouse
embryos as well as zebrafish single morphants (Becker et al., 2014;
John et al., 1995; Tamura et al., 2000). In contrast, double
homozygous nppauq19ks/uq19ks/nppbuq20ks/uq20ks embryos displayed
pericardial oedema starting at 48 hpf (Fig. 1D-H). The penetrance of
the phenotype was incomplete and the expressivity variable.
Approximately 20% of double mutants presented a wild-type
phenotype and, in the remaining 80% of the genotypically mutant
embryos, pericardial oedema was accompanied by additional
cardiac abnormalities, such as looping defects or blood
regurgitation at the inflow tract, or both (Fig. 1H; Movie 1). One
day later, the penetrance increased (Fig. 1H). These data confirm
that Nppa and Nppb do indeed function redundantly and play a role
during vertebrate cardiac development.
To establish whether compensation at the level of gene expression
exists between nppa and nppb, we performed in situ hybridisation
expression analysis on both single and double mutant embryos
(Fig. 1C, Fig. S1). The intensity of both nppa or nppb staining was
unaltered at all stages and genotypes analysed, with the exception of
nppb (Fig. 1C and Fig. S1). To quantify the expression of nppa and
nppb levels in order to address the issue of compensation, we
performed Q-PCR analysis on single nppa and nppb mutant
embryos compared with wild-type sibling controls. No significant
difference was observed for any groups tested (Fig. S1). This
Fig. 1. Nppa and Nppb play redundant roles during early cardiac development. (A) Schematic of the zebrafish nppb and nppa gene cluster (on chromosome
8) and respective nppb CRISPR/Cas9 (base pair 239) and nppa TALEN cleavage sites (base pair 54). Sanger sequencing show three alleles of nppa and nppb
genes identified following genome editing (nppauq19ks, nppbuq20ks and nppbuq21ks). (B) Schematics of Nppa and Nppb wild-type and mutant proteins.
Numbers indicate predicted amino acid positions. (C) In situ hybridisation for nppa and nppb on sibling and double mutant embryos at 48 hpf demonstrate overtly
wild-type morphology of double mutant hearts. nppa gene expression is unaltered in double mutants, whereas nppb appears decreased in double mutants. (D-G)
Lateral bright-field images of representative 72 h post-fertilisation (hpf) sibling and double mutant embryos. Black arrow indicates the pericardial oedema
observed in double mutants. (H) Pie charts illustrate the penetrance and expressivity of the phenotype at 48 hpf and 72 hpf.
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demonstrates that there is no compensation occurring for these
genes and is consistent with reports that nppa and nppb are co-
regulated (Becker et al., 2012; Sergeeva et al., 2016, 2014).
Cardiomyocyte number and size, and cardiac output are all
unchanged in double mutants
Previous studies inhibiting nppa and nppb expression via double
morpholino knockdown have described increased cardiomyocyte
numbers in double morphant embryos (Becker et al., 2014). To
examine whether we observe a difference in cardiomyocyte number
in double mutant versus sibling embryos, we crossed double
heterozygous carriers onto the Tg(myl7:dsRed-nls) background
(labelling cardiomyocyte nuclei) and quantified cell number from
confocal z-stack images. In contrast to double morpholino-treated
embryos, we observed no significant difference in cardiomyocyte
number in double mutant embryos compared with siblings
(Fig. 2A,A′).
Natriuretic peptides are well known for counteracting cardiac
hypertrophy (Lerman et al., 1993; Vanderheyden et al., 2004) and,
conversely, mice null for Nppa or the receptor shared by Nppa and
Nppb, Npr1, display cardiac enlargement and augmented
cardiomyocyte diameter (Ellmers et al., 2007; Holtwick et al.,
2003; John et al., 1995). Quantifying cardiomyocyte size in double
mutant hearts compared with siblings demonstrated no difference
between double mutants and siblings (Fig. 2B,B′). Although this
result is in contrast with that observed inNppa−/− andNpr1−/−mice,
these previous studies examine effects after months of Nppa
deficiency (Ellmers et al., 2007; John et al., 1995). It is perhaps this
chronic loss of Nppa signalling that accounts for the discrepancy
between our work and previous reports.
Next, to investigate heart function of double mutants, high-speed
imaging of siblings and double mutants was performed. By
observing movies of siblings versus double mutant hearts, blood
flow appeared slower when examining the inflow tract of beating
hearts, which would account for the pericardial oedema observed in
double mutant embryos (Movie 1). However, quantitative
measurements of stroke volume and ejection fraction showed no
significant difference between sibling and mutant embryos
(Fig. S2). These measurements rely on comparable morphology
between different groups being measured. Considering the
distention of the hearts observed from pericardial oedema, this is
likely to have impaired measurements and may account for the lack
of functional difference detected between siblings and mutants.
AVC markers are expanded and the cardiac jelly appears
thicker in double mutant embryos
Given the repressive role Tbx2 plays on Nppa expression
(Christoffels et al., 2004; Habets et al., 2002), we sought to
investigate whether a reciprocal repressive function for Nppa on
AVC-restricted gene expression takes place. To examine this, we
performed in situ hybridisation analysis for a range of AVCmarkers
in sibling and double mutant embryos. Interestingly, expression of
all markers tested, namely bmp4, tbx2b, has2 and versican, was
expanded in double mutant embryos at 72 hpf (Fig. 2C,D). To
investigate whether this resulted in a concomitant increase in the
number of cells transitioning to endocardial cushion (EC) identity,
immunostaining for Alcama on the Tg(fli1a:nEGFP)y7 transgenic
line was performed and EC cell number quantified. Surprisingly, no
significant difference was observed in the number of EC cells
between sibling and double mutant embryos (Fig. S3). Instead, the
expansion of AVC marker gene expression appears to affect
thickening of the jelly between the layers of the cardiac wall. When
high-speed movies from Fig. S2 and Movie 1 were examined
closely, an increased endocardial-to-myocardial thickness was
consistently observed in double mutant embryos. To quantify this,
Fig. 2. AVCmarkers are expanded in double mutant embryos and cardiac
jelly is thicker. (A) Confocal z-stacks of Tg(myl7:dsRed-nls) embryos
(labelling cardiomyocyte nuclei) show no difference in cell number between
sibling and double mutant embryos. (A′) Graphical representation of cell
number (n=11 siblings; n=14 mutants). (B) Confocal images of representative
sibling and double mutant embryos immunostained for Alcama to visualise cell
shape. IC, inner curvature (white asterisk); OC, outer curvature (white
arrowhead); AVC, atrioventricular canal (white arrow). Individual
cardiomyocytes are outlined with broken lines. (B′) Graph showing average
cardiomyocyte size of ventricle and atrium in siblings and double mutants
(n=11 siblings; n=12 mutants). (C) In situ hybridisation analysis of AVC
markers bmp4, tbx2b, has2 and versican are expanded into the atrial chamber
of double mutants compared with siblings. (E) Bright-field still images from
high-speed movies of hearts at atrial diastole show thickened space (outlined)
between the myocardial outer surface and the lumen surface of the heart,
indicating thicker cardiac jelly in double mutants. (E′) Quantification of cardiac
jelly thickness showing a significant increase in double mutant embryos
compared with wild-type siblings when measuring the outer atrial myocardial
wall and the inner luminal lining (n=10 siblings; n=11 mutants). ns, not
significant; *P<0.05, as determined by t-test. Data are mean±s.d.
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the area from the outer surface of the atrial myocardium to the
luminal surface of the heart was measured and a significant
difference was observed between sibling and double mutant
embryos (Fig. 2E,E′).
ssNcan-GFP is a biosensor for the cardiac jelly
We recently reported a genetically encoded biosensor to detect HA
in the developing embryo (De Angelis et al., 2017), using a similar
approach used in cultured cells (Zhang et al., 2004). This biosensor
uses the HA-binding domain of the protein, Neurocan, fused to
EGFPwith a synthetic secretion sequence to export it extracellularly
and localise it to HA. Given that HA is a major component of the
cardiac jelly, we applied this tool to examine double mutant
embryos. Although transient mRNA injection could be used for
analysing early stages of zebrafish development, we found poor
reproducibility by 48 hpf in the cardiac jelly.We therefore generated
a stable transgenic line, Tg(ubi:ssNcan-EGFP)uq25bh, using the
ubiquitin (ubi) promoter and observed robust and reproducible
localisation of EGFP in the cardiac jelly (Fig. 3 and Movie 2). To
validate that ssNcan-EGPF was indeed indicative of HA localisation
and not simply an accumulation of secreted protein, we generated a
ubiquitously expressing secreted GFP transgenic line [Tg(ubi:
ssEGFP)uq7ks] and found that, not only did it have different GFP
localisation from Tg(ubi:ssNcan-EGFP), but almost no GFP was
detected in the cardiac jelly (Fig. 3 and Movie 2), substantiating the
use of the Tg(ubi:ssNcan-EGFP) line as a biosensor for HA and the
cardiac jelly.
The cardiac jelly is increased in nppa/nppb double mutant
hearts
To measure the cardiac jelly phenotype observed in Fig. 2E, we
crossed double nppa/nppb carriers onto the Tg(ubi:ssNcan-EGFP)
background and took confocal z-stacks of the hearts of anaesthetised
live zebrafish. An obvious expansion of the fluorescent area was
observed in double mutant embryos. Quantification showed a
significant increase in ssNcan-EGFP area in the atrium but not
ventricle of double mutants compared with siblings (Fig. 4A,B).
Interestingly, this correlated with the region of AVC marker gene
expansion: into the atrium but not the ventricle. Of note, this included
the ECM-synthetic genes has2 and vesican. In vivo and in vitro
models have previously demonstrated that Nppa and Nppb exert anti-
fibrotic function by inhibiting TGF-β-mediated fibroblast
transformation and the production of ECM proteins (Ellmers et al.,
2007; Horio et al., 2003; Li et al., 2008; Tamura et al., 2000; Tsuruda
et al., 2002; Wang et al., 2003). We show here, that Nppa and Nppa
exert a similar effect on ECMproduction during cardiac development.
Fig. 3. A transgenic biosensor for the
cardiac jelly. (A) Lateral view of the Tg(ubi:
ssNcan-EGFP) line: a biosensor for hyaluronic
acid – a major constituent of the cardiac jelly.
The sensor expresses a secreted fusion protein
of the HA-binding domain of Neurocan fused to
GFP, driven by the ubi promoter. The biosensor
localises to regions of HA, including the cardiac
jelly, the otic vesicle and around the
vasculature. (B) The Tg(ubi:ssEGFP) control
was also generated and shows different EGFP
localisation, predominantly to the skeletal
muscle. Scale bars: 100 µm. (C,C′) Frontal view
images of 48 hpf Tg(ubi:ssNcan-EGFP)/
Tg(kdrl:mCherry) hearts anaesthetised and live
imaged showing the cardiac jelly (green) and
endocardial layer (red). ssNcan-EGFP
localises tomucous cells (black arrowhead) and
is concentrated at the AVC (asterisks). Regions
devoid of ssNcan-EGFP in the cardiac jelly due
to protruding endocardial cells can also be
observed (white arrowheads). (D,D′) Live
images of 48 hpf Tg(ubi:ssEGFP)/Tg(kdrl:
mCherry) hearts showing near undetectable
amounts of ssEGFP localisation (for full
z-stacks of C,D, see Movie 2). (E,E′) Live
images of 72 hpf Tg(ubi:ssNcan-EGFP)/
Tg(kdrl:mCherry) ventricles showing
condensed jelly and sites of trabeculae
formation. (F,F′) Live images of 72 hpf Tg(ubi:
ssEGFP)/Tg(kdrl:mCherry) hearts showing
ssEGFP localisation in the pericardial space.
Scale bar: 20 µm.
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Existence of a regulatory loop between Nppa/Nppb, Bmp4
and Tbx2
Given the observed increase in bmp4 expression in nppa/nppb
double mutants and the knowledge that has2 expression is
downstream of Bmp signalling (Shirai et al., 2009), we investigated
whether inhibition of Bmp signalling is sufficient to rescue the has2
expansion in doublemutants.We injected previously published bmp4
morpholinos (Chocron et al., 2007) into a clutch of incrossed double
heterozygous carriers, grew them until 72 hpf, performed has2 in situ
hybridisation, imaged and categorised embryos then genotyped them.
We observed a robust expansion of has2 into the atrial chamber of
double mutant embryos (as observed in Fig. 2). However, bmp4
knockdown rescued the has2 expression pattern to that of uninjected
sibling controls (Fig. 4C,D).
To investigate whether the expanded cardiac jelly in double
mutants was also downstream of Bmp signalling, we injected bmp4
morpholinos into nppa/nppb double mutants on the Tg(ubi:ssNcan-
EGFP) background and measured cardiac jelly area. As observed
Fig. 4. The amount of cardiac jelly is increased in doublemutant embryos and the AVCexpansion is downstreamof Bmp4 signalling. (A) Representative
confocal stacks of the cardiac jelly in siblings versus double mutant embryos (ventral view, head towards the top), demonstrating thicker cardiac jelly (outlined) in
double mutant embryos at 72 hpf. (B) Dot plot depicting themeasurement of cardiac jelly area, showing no significant difference (ns) in jelly thickness of ventricles
of siblings versus mutants, whereas significantly more jelly in the atrium of double mutants compared with siblings is observed (n=10; *P<0.05; two-tailed t-test).
Data are mean±s.d. (C) Representative images of embryos following in situ hybridisation for has2 expression in sibling and double mutant embryos. Images show
categories of has2 expression in embryos at 72 hpf. The heart is outlined. (D) The proportion of embryos with different categories of has2 expression in wild-type
(n=13), double heterozygotes (n=34) and double mutant (n=10) embryos in uninjected controls or in wild-type (n=5), double heterozygotes (n=9) and double
mutant (n=8) embryos following bmp4 knockdown. The proportion of phenotypes in double mutant embryos injected with bmp4 morpholino most closely
resembles uninjected double heterozygotes, demonstrating restoration of has2 expression upon bmp4 knockdown. (E) Representative confocal stacks of Tg(ubi:
ssNcan-EGFP) to visualise the cardiac jelly in siblings versus double mutant embryos at 72 hpf, either uninjected or injected with bmp4morpholino. (F) Dot plots
depicting the measurement of cardiac jelly area in atria of sibling versus double mutant embryos. A significant increase in the jelly area is observed between
uninjected siblings and double mutants (n=11; ***P<0.01; two-way ANOVA for multiple comparisons with Tukey’s post hoc correction). No significant difference
(ns) is observed in the jelly area between siblings and double mutants following bmp4morpholino injection (n=16 siblings; n=11 double mutants), demonstrating
that the increase in the cardiac jelly thickness is restored following bmp4 morpholino injection. Two-tailed t-test; data are mean±s.d. Scale bar: 30 μm.
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for has2 gene expression, the increased area of cardiac jelly in the
atrium was restored to that of siblings following bmp4 knockdown.
We repeated this analysis using DMH1, a chemical inhibitor of Bmp
signalling and, again, observed the cardiac jelly area restored to that
of siblings (Fig. S4). Together, these data suggest that nppa/nppb
disruption results in ectopic bmp4 transcription into the atrial
chamber, and in a resultant increase in HA synthesis and production
of cardiac jelly.
These data demonstrate that Nppa and Nppb are required to
repress the AVC genetic program within the atrial chamber,
providing complementarity to the activity of Tbx2b in the AVC,
which represses the chamber genetic program, including nppa and
nppb. This mutually exclusive repressive activity must assist in
establishing a sharp boundary between these two tissue
compartments. Presumably, these ligands perform this function
via receptor-mediated signalling, although this remains to be tested.
What is still unknown is how receptor-mediated signalling acts
to repress bmp4. We show that Nppa/Nppb signalling functions
to inhibit bmp4 transcription in the chambers, repressing the
Bmp>Tbx2>Has2 cascade. The most noteworthy outcome of nppa/
nppb deficiency is increased transcription of the extracellular matrix
components versican and overproduction of HA.
In summary, these data reveal a previously unappreciated role for
Nppa and Nppb in cardiac development. Zebrafish nppa/nppb
double mutants develop pericardial oedema as early as 48 hpf. The
functional consequence of losing Nppa/Nppb is unrestricted AVC
boundary establishment, resulting in ectopic production of cardiac
jelly in the atrial chamber. This role for Nppa/Nppb in restricting the
Bmp-Tbx2-Has2 pathway from the chamber to the AVC, places
Nppa/Nppb in a regulatory loop with Tbx2, upstream of Bmp.
MATERIALS AND METHODS
Zebrafish lines and transgenesis
All zebrafish strains were maintained and animal work performed in
accordance with the guidelines of the animal ethics committee at The
University of Queensland, Australia. The previously published transgenic
lines used are Tg(myl7:dsRed-nls) (Mably et al., 2003); Tg(kdrl:mCherry)
(Hogan et al., 2009) and Tg(fli1a:nEGFP)y7 (Lawson andWeinstein, 2002).
Generation of the Tg(ubi:ssEGFP) and Tg(ubi:ssNcan-EGFP) lines was
performed by injecting 1 nl of 25 ng/μl purified plasmid DNA (constructs
described by De Angelis et al., 2017) into single-cell stage embryos together
with tol2 transposase mRNA (25 ng/μl). Embryos expressing EGFP
mosaically were selected and raised to adulthood, and screened for
germline transmission to generate stable transgenic lines.
Genome editing
TALEN monomers (Table S2) for nppa were generated using the golden
gate kit (Cermak et al., 2011), cloned into the pCS2TAL3RR and
pCS2TAL3DD backbones, and transcribed as previously described
(Dahlem et al., 2012). CRISPR gDNA (Table S2) and co-injection with
cas9 mRNA for targeting nppb was performed as described (Capon et al.,
2017). Fish were screened by high-resolution melt analysis (HRMA) using a
Viia7 Real-Time PCR System (Applied Biosystems) and F1 embryos
carrying a 4 bp deletion and 10 bp insertion for nppa and nppb, respectively,
were outcrossed to the wild-type strain to generate an F2 population. To
generate double mutants, nppa homozygous fish were incrossed and nppb
CRISPR/Cas9 RNA injected into embryos. F1 embryos identified with a
39 bp insertion for nppb were outcrossed to the wild-type strain to generate
an F2 population. Primers for HRMA and sequencing of individual
mutations are listed in Table S2.
In situ hybridisation and antibody staining and MO injections
In situ hybridisation analysis was carried out as previously described
(Smith et al., 2011). Immunohistochemistry was performed as previously
described (Smith et al., 2008). Antibody details are provided in Table S2.
The splice-targeting bmp4 MO was used as previously described
(Chocron et al., 2007). The standard p53 control MO from Gene Tools
was used.
Q-PCR analysis
DNA was extracted from the trunk of 48 hpf individual embryos as
previously described (Dahlem et al., 2012) and genotyped by PCR using
primer sequences depicted in Table S1. Following amplification, digestion
with BsrGI-HF which cuts the wild-type sequence, was performed and
successful digest resolved by agarose gel electrophoresis. nppb embryos
were genotyped by PCR using primer sequences from Table S1, which
amplify wild-type and mutant amplicons (10 bp or 39 bp insertion) resolved
by electrophoresis on a 2.5% sodium boric acid gel (Brody and Kern, 2004)
at 200 V.
RNA was subsequently extracted from the remaining head/heart from a
pool of four mutants or wild-type siblings in triplicate using a Direct-zol kit
(Zymol Research) as per the manufacturer’s guidelines. qPCR for nppa and
nppb was performed on a Viia 7 system (Applied Biosystems). Efficiency
corrected data was normalised to the geometric average of ef1α and rpl13
using GeNorm (Vandesompele et al., 2002) as previously described (Coxam
et al., 2014).
DMH1 inhibitor treatment
DMH1 was dissolved in DMSO. The DMSO control and DMH1 in DMSO
were diluted with E3 medium to a concentration of 1 µM. Embryos were
dechorionated and incubated in either DMSO or DMH1 solutions for 24 h
(from 48-72 hpf), their hearts stopped with Tricaine and live imaging
performed.
Live and fixed tissue imaging
Whole-mount in situ hybridisation embryos were imaged using an Olympus
BX51 Upright Microscope Stand with Olympus DP70 CCD camera (10×
dry objective). Confocal imaging was performed on a Zeiss Axiovert 200
Inverted Microscope Stand with LSM 710 Meta Confocal Scanner using
20× and 40× dry objectives (Zeiss Zen 2012 Black Software). High-speed
movies (100 fps) were acquired using a Nikon Ti-E Inverted Stand with
Hamamatsu Flash 4.0 sCMOS camera (20× dry objective - NIS Elements
4.3 Software). Fixed and live embryos for confocal imaging, as well as live
embryos for movie acquisition, were mounted in low-melting point 1%
agarose (Sigma-Aldrich).
Assessment of wall thickness and HA staining extent
Wall thickness was measured from movie acquisitions. Files were opened
with the ImageJ 2.0.0 Software and individual frames analysed. The inner
surface (IS) of the heart (as delimited by the endocardium) was subtracted
from the myocardium-lined outer surface, in order to obtain the overall
cardiac wall area. This value was normalised against the overall
perimeter, calculated as the arithmetic mean of inner and outer
perimeters. For each embryo, the corresponding wall thickness was
obtained by averaging the measurements of three consecutive beating
events. The extent of HA staining in the atrium was measured from
confocal acquisitions of Tg(ubi:ssNcan-EGFP) embryos, calculating the
ratio of EGFP-labelled area out of the total chamber area. For each
embryo, the final value was the average of three measurements on
subsequent optical sections, chosen to be at the level of the
atrioventricular canal (AVC) and inflow tract. As for the quantification
of HA in the ventricle (see Fig. 4A,B), relevant sections were selected to
allow as clear a visualisation of the chamber inner and outer outlines as
possible, preferably at the level of the AVC.
Image and statistical analyses
Image analysis and quantification was performed using Fiji (ImageJ 2.0.0
Software). Measurements of cell size were conducted as previously
described (Auman et al., 2007). All cellular measurements were
performed on three cells per condition from at least three different
embryos. Movie analyses to determine ‘stroke volume’ and ‘ejection
fraction’ were performed as described previously (Bagatto and Burggren,
2006). For statistical analysis, Gaussian distribution of the data and equal
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variance among groups was assumed although not formally tested. The
unpaired, two-tailed Student’s t-test or two-way ANOVA followed by
Tukey’s post hoc test for multiple comparisons was employed (Prism 7.0a
Software), as reported in figure legends.
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